IM Cannabis (IMCC) Receivables - Net (2019 - 2026)
IM Cannabis' (IMCC) quarterly Receivables - Net came in at $5.2 million in Q1 2026, down 54.97% year-on-year from $11.6 million in Q1 2025, and down 32.82% quarter-over-quarter from $7.8 million in Q4 2025.
IM Cannabis (IMCC) Receivables - Net (2019 - 2026) Analysis & Trends
IM Cannabis' Receivables - Net history runs 8 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- On a quarterly basis, Receivables - Net fell 54.97% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $5.2 million, a 54.97% decrease from a year earlier, with the FY2025 full-year figure at $7.8 million, down 22.84% from the prior year.
- Receivables - Net retreated to $5.2 million in Q1 2026 per IMCC's latest filing, from $7.8 million in the prior quarter.
- Across five years, Receivables - Net topped out at $17.5 million in Q1 2022 and bottomed at $4.6 million in Q1 2023.
- The 5-year median for Receivables - Net is $8.2 million (2025), against an average of $8.8 million.
- Across the five-year window, Receivables - Net plunged 73.66% in 2023 and soared 140.37% in 2025, its largest moves.
- Year by year, Receivables - Net stood at $6.4 million in 2022, then dropped by 12.15% to $5.6 million in 2023, then soared by 75.82% to $9.9 million in 2024, then slipped by 21.27% to $7.8 million in 2025, then tumbled by 32.82% to $5.2 million in 2026.
- Per Business Quant, the three latest IMCC Receivables - Net figures stand at $5.2 million (Q1 2026), $7.8 million (Q4 2025), and $8.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.23 Mn |
| Mar 31, 2026 | 5.23 Mn |
| Dec 31, 2025 | 7.78 Mn |
| Dec 31, 2025 | 7.78 Mn |
| Sep 30, 2025 | 8.18 Mn |
| Sep 30, 2025 | 8.18 Mn |
| Jun 30, 2025 | 9.03 Mn |
| Jun 30, 2025 | 9.03 Mn |
| Mar 31, 2025 | 11.61 Mn |
| Mar 31, 2025 | 11.61 Mn |
| Dec 31, 2024 | 9.88 Mn |
| Dec 31, 2024 | 9.88 Mn |
| Sep 30, 2024 | 10.56 Mn |
| Sep 30, 2024 | 10.56 Mn |
| Jun 30, 2024 | 8.84 Mn |
| Jun 30, 2024 | 8.84 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Dec 31, 2023 | 5.62 Mn |
| Dec 31, 2023 | 5.62 Mn |